Remission of Cap Polyposis Maintained for More Than Three Years after Infliximab Treatment

Cap polyposis is a rare disorder with characteristic endoscopic and histological features; its etiology is still unknown, and no specific treatment has been established. We report a case of cap polyposis that improved remarkably after infliximab infusion and had no recurrence for 3 years.

Detalles Bibliográficos
Autores principales: Kim, Eun Sun, Jeen, Yoon Tae, Keum, Bora, Seo, Yeon Seok, Chun, Hoon Jai, Um, Soon Ho, Kim, Chang Duck, Ryu, Ho Sang
Formato: Texto
Lenguaje:English
Publicado: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852720/
https://www.ncbi.nlm.nih.gov/pubmed/20431770
http://dx.doi.org/10.5009/gnl.2009.3.4.325
Descripción
Sumario:Cap polyposis is a rare disorder with characteristic endoscopic and histological features; its etiology is still unknown, and no specific treatment has been established. We report a case of cap polyposis that improved remarkably after infliximab infusion and had no recurrence for 3 years.

Ejemplares similares